Topics

"Measure High Value Aspects Primary Care" Drugs and Medication Database

23:42 EDT 21st July 2019 | BioPortfolio

Here are the most relevant "Measure High Value Aspects Primary Care" Drugs and Medications that we have found in our database.

More Information about "Measure High Value Aspects Primary Care" on BioPortfolio

We have published hundreds of Measure High Value Aspects Primary Care news stories on BioPortfolio along with dozens of Measure High Value Aspects Primary Care Clinical Trials and PubMed Articles about Measure High Value Aspects Primary Care for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Measure High Value Aspects Primary Care Companies in our database. You can also find out about relevant Measure High Value Aspects Primary Care Drugs and Medications on this site too.

Showing "Measure High Value Aspects Primary Care" Drugs and Medications, all 5

Possibly Relevant

Aridol bronchial challenge test kit [methapharm, inc.]

These highlights do not include all the information needed to use ARIDOL safely and effectively. See full prescribing information for ARIDOL. ARIDOL (mannitol inhalation powder) Bronchial Challenge Test Kit Initial U.S. Approval: 1964

Sotylize [arbor pharmaceuticals, inc.]

These highlights do not include all the information needed to use SOTYLIZE safely and effectively. See full prescribing information for SOTYLIZE. SOTYLIZE (sotalol hydrochloride) oral solutionInitial U.S. Approval: 1992

Sorine [upsher-smith laboratories, inc.]

These highlights do not include all the information needed to use SORINE safely and effectively. See full prescribing information for SORINE. SORINE (sotalol hydrochloride) tablets, for oral useInitial U.S. Approval: 1992

Benzonatate [redpharm drug inc.]

Benzoate Capsules

Xyosted [antares pharma, inc.]

These highlights do not include all the information needed to use XYOSTED safely and effectively. See full prescribing information for XYOSTED. XYOSTED (testosterone enanthate) injection, for subcutaneous useCIIIInitial U.S. approval: 1953



Quick Search